These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 26496031
1. Inhibition of iNOS activity enhances the anti-tumor effects of alpha-galactosylceramide in established murine cancer model. Ito H, Ando T, Seishima M. Oncotarget; 2015 Dec 08; 6(39):41863-74. PubMed ID: 26496031 [Abstract] [Full Text] [Related]
8. Inhibition of induced nitric oxide synthase enhances the anti-tumor effects on cancer immunotherapy using TLR7 agonist in mice. Ito H, Ando T, Ogiso H, Arioka Y, Seishima M. Cancer Immunol Immunother; 2015 Apr 15; 64(4):429-36. PubMed ID: 25567751 [Abstract] [Full Text] [Related]
9. Role of γδ T cells in α-galactosylceramide-mediated immunity. Paget C, Chow MT, Duret H, Mattarollo SR, Smyth MJ. J Immunol; 2012 Apr 15; 188(8):3928-39. PubMed ID: 22412194 [Abstract] [Full Text] [Related]
18. Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide. Yanagisawa K, Exley MA, Jiang X, Ohkochi N, Taniguchi M, Seino K. Cancer Res; 2006 Dec 01; 66(23):11441-6. PubMed ID: 17145891 [Abstract] [Full Text] [Related]